Practical measures are paramount for robust medicines manufacturing

9 September 2020

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Future and Challenges of the Pharmaceutical Industry

14 November 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

21 December 2017

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017